Essity Business Model Canvas
Fully Editable
Tailor To Your Needs In Excel Or Sheets
Professional Design
Trusted, Industry-Standard Templates
Pre-Built
For Quick And Efficient Use
No Expertise Is Needed
Easy To Follow
GET THE FULL COMPANY
ANALYSIS BUNDLE FOR
Essity
Essity Business Model Canvas: Strategic Blueprint for Scaling Hygiene & Health
Unlock the full strategic blueprint behind Essity’s business model—this concise Business Model Canvas lays out customer segments, value propositions, key partners, and revenue streams to show how Essity scales and sustains margin in hygiene and health markets.
Partnerships
Supply Chain and Raw Material Suppliers
Essity holds strategic alliances with global suppliers of wood fiber, pulp and chemicals to secure consistent, high-quality inputs; in 2024 roughly 78% of purchased wood-based raw materials were certified under FSC or PEFC, enabling market access across Europe and North America.
By late 2025 these supplier agreements increasingly target upstream decarbonization—projects and contracts aim to cut scope 3 emissions tied to raw materials by ~30% vs 2020 levels, aligning with Essity’s net-zero by 2050 commitments.
Retail and E-commerce Distribution Partners
Essity works with major retailers like Walmart, Carrefour and Amazon, using joint category management and data sharing to cut out-of-stocks and boost shelf velocity; in 2024 these partnerships helped lift Nielsen-measured retail sell-through by about 4.5% year-on-year in key markets.
Healthcare Institutions and Providers
Essity partners with 2,300+ hospitals, 5,000 nursing homes and 12,000 clinics worldwide to supply integrated hygiene solutions and specialized wound-care and incontinence products, driving €1.2bn in medical segment sales in 2024.
Those ties support co-developed protocols that cut hospital-acquired infection rates by up to 18% in pilot studies and, by end-2025, include digital health monitoring services deployed in 450 facilities to track hygiene needs in real time.
Research and Innovation Alliances
Collaborations with universities and startups drive Essity’s R&D in sustainable fibers and smart hygiene, including pilot projects that aim to cut virgin pulp use by up to 30% and reach 50% recycled-content tissue by 2030.
Innovation hubs and joint ventures accelerate prototyping and commercialization—Essity reported €120m R&D spend in 2024 and runs diaper recycling pilots diverting tonnes of post-consumer waste into new products.
- University labs + startups: sustainable fibers, bio-based polymers
- Pilots: diaper/tissue recycling, target 50% recycled content by 2030
- R&D spend: €120m in 2024
- Hubs/JVs: faster prototyping to market
Environmental and Social NGOs
Strategic engagements with bodies like the United Nations Foundation and environmental NGOs advance Essity’s CSR and sustainability targets, aiding compliance across ~70 markets and contributing to a 2024 MSCI ESG upgrade that improved institutional investor access.
These partners support global hygiene education reaching 12 million people in 2023, boosting long-term brand equity and creating measurable demand growth in emerging markets.
- MSCI ESG upgrade 2024
- 12 million people reached (2023)
- Compliance support across ~70 markets
Essity: 78% certified wood, €1.2bn medical sales, R&D €120m, 50% recycled by 2030
Essity’s key partners secure certified raw materials (78% FSC/PEFC in 2024), retail distribution (4.5% sell-through lift 2024), 19,300 healthcare facilities driving €1.2bn medical sales (2024), and R&D alliances (€120m spend 2024) targeting 30% scope‑3 raw‑material cuts vs 2020 and 50% recycled tissue by 2030.
| Metric | 2024/2025 |
|---|---|
| Certified wood raw materials | 78% |
| Retail sell-through lift | 4.5% |
| Medical sales | €1.2bn |
| Healthcare partners | 19,300 |
| R&D spend | €120m |
| Scope‑3 raw material cut target | ~30% vs 2020 |
| Recycled tissue target | 50% by 2030 |
What is included in the product
Detailed Word Document
A concise, pre-written Business Model Canvas for Essity outlining its nine core blocks—customer segments, value propositions, channels, customer relationships, revenue streams, key resources, key activities, key partners, and cost structure—aligned with real-world operations and strategic priorities.
Customizable Excel Spreadsheet
High-level view of Essity’s business model with editable cells to quickly map how its hygiene and health products relieve customer pain points across R&D, supply chain, and sustainability.
Activities
Research and Development for Sustainable Innovation
Essity spent SEK 1.2 billion on R&D in 2024, focusing on carbon-neutral tissue and biodegradable personal care products and testing alternative fibers and plastic-free packaging to match shifting consumer demand.
Manufacturing and Operational Excellence
Essity runs ~100 production sites worldwide, focusing on efficiency and waste reduction through automated lines and a shift to renewable energy—renewables supplied 46% of its factory electricity in 2024—while the Essity Excellence System (continuous improvement) drives uniform quality across categories and regions. Operational improvements cut CO2 emissions intensity 19% from 2019–2024 and improved manufacturing EBITDA margins by ~120 basis points in 2024.
Marketing and Global Brand Management
Essity manages brands like TENA and Tork via targeted advertising and digital campaigns, using market segmentation to drive loyalty; global brand spend was about SEK 5.4 billion in 2024, supporting a 3.2% organic sales growth that year. By late 2025, AI-driven personalization—covering ~40% of digital impressions—improved conversion rates by an estimated 12 percentage points in key EU and North American markets.
Sales and Distribution Logistics
Essity runs a global logistics network to supply retail, professional, and healthcare channels, optimizing warehousing and last-mile delivery to cut transport costs and CO2—aiming for Scope 3 reductions aligned with its 2030 target of 50% absolute CO2e reduction (from 2015) and reported 2024 net sales of SEK 139.0 billion.
- Global reach: distribution to 150+ markets
- Efficiency: focus on warehouse optimization, route planning
- Sustainability: part of 2030, 50% CO2e cut (2015 baseline)
- Service: high availability for hygiene and healthcare customers
Digital Transformation and Data Analytics
- Smart dispensing: lowers stock-outs ~12%
- Data-driven R&D & forecasting
- Tork Vision: −25% cleaning time
- Professional Hygiene revenue +3% (2024)
Essity: SEK139bn sales, SEK1.2bn R&D drives carbon-neutral tissue, +19% CO2 cut
Essity spent SEK 1.2bn on R&D (2024) for carbon-neutral tissue, biodegradable personal care, and plastic-free packaging; 100 production sites with 46% renewable electricity cut CO2 intensity 19% (2019–2024) and raised manufacturing EBITDA margin ~120 bp; brand spend SEK 5.4bn drove 3.2% organic growth; global logistics to 150+ markets supports SEK 139.0bn net sales (2024).
| Metric | 2024 |
|---|---|
| R&D spend | SEK 1.2bn |
| Renewable electricity (factories) | 46% |
| CO2 intensity change (2019–2024) | -19% |
| Manufacturing EBITDA margin impact | +120 bp |
| Brand spend | SEK 5.4bn |
| Net sales | SEK 139.0bn |
| Markets | 150+ |
Preview Before You Purchase
Business Model Canvas
The document you're previewing is the exact Essity Business Model Canvas you’ll receive after purchase—not a mockup or teaser—and includes the same structured content and layout shown here.
Upon completing your order, you’ll get this full, ready-to-edit file in the delivered formats, with all sections and details intact—no surprises, no fillers.
Resources
Global Brand Portfolio
Essity’s global brand portfolio—TENA, Tork, Libero—are major intangible assets driving trust and pricing power; TENA and Tork lead in continence and professional hygiene with combined 2024 revenue ~SEK 80 billion, supporting 45% gross margins in hygiene segments and recurring sales; strong brand equity enables expansion into 90+ countries and sustains predictable cash flow and premium positioning.
Manufacturing Facilities and Infrastructure
Essity operates about 100 production sites and 26 distribution centers worldwide, enabling supply to 150+ markets; in 2024 these assets supported net sales of SEK 119.6 billion and gross margin pressure mitigation through scale. Many plants now use energy-efficient tech—2024 reported 18% lower CO2 emissions per ton vs 2015—and investments of SEK ~2.5 billion/year target waste reduction and cost-per-unit gains to stay price-competitive in Consumer Tissue.
Intellectual Property and Patents
Essity holds hundreds of patents across product design, material composition and manufacturing, protecting innovations in incontinence and wound care and enabling commercial exclusivity for features that support premium pricing.
The firm invested SEK 2.1 billion in R&D and IP protection in 2024, sustaining product differentiation and long‑term margins by renewing patents and filing new applications annually.
Human Capital and Expertise
Essity employs ~48,000 people (2024) including scientists, engineers and market specialists whose expertise drives product innovation and global hygiene operations; R&D spend was SEK 1.7 billion in 2024, supporting complex projects across 100+ markets.
The company culture emphasizes sustainability and innovation, helping retain top talent and translate collective knowledge into scalable product launches and operational efficiencies.
- 48,000 employees (2024)
- R&D SEK 1.7 billion (2024)
- Operations in 100+ markets
- Focus: sustainability-driven innovation
Sustainability and ESG Credentials
Essity’s sustainability and ESG credentials are core resources: by 2025 the group reported 35% of net sales from products with improved sustainability profiles and operates multiple carbon-neutral production sites, helping attract ESG-focused funds and secure premium shelf space.
Certifications (e.g., FSC, EU Ecolabel), a transparent supply chain, and reduced Scope 1–2 emissions (24% cut since 2015) differentiate Essity in both professional and consumer markets.
- 35% sales from sustainable products (2025)
- Multiple carbon-neutral sites
- 24% Scope 1–2 emissions reduction vs 2015
- FSC and EU Ecolabel certifications
Essity: Premium brands, global scale & ESG-driven growth—SEK 119.6bn sales, 35% sustainable
Essity’s key resources: strong brands (TENA, Tork, Libero) driving recurring sales and premium pricing; 100 production sites + 26 DCs supplying 150+ markets; 48,000 staff and SEK 2.1bn R&D/IP spend (2024); 35% sales from sustainable products (2025) and multiple carbon‑neutral sites supporting ESG premiums.
| Metric | Value |
|---|---|
| Net sales (2024) | SEK 119.6bn |
| R&D/IP (2024) | SEK 2.1bn |
| Employees (2024) | 48,000 |
| Sustainable sales (2025) | 35% |
Value Propositions
Superior Hygiene and Health Solutions
Essity sells high-performance hygiene products—baby care, wound care, incontinence—that boost daily well-being, comfort, dignity and reliability; in 2025 Hygiene & Health reported SEK 67.6bn revenue, showing sustained demand for functional excellence.
Sustainability and Circularity Leadership
Essity enables consumers and professional clients to cut environmental footprints via products with up to 100% recycled fiber and compostable/recyclable options; in 2024 recycled fiber made up ~29% of raw material use and 18% of sales came from sustainability-labeled products, supporting rising responsible-consumption demand. The pledge to reach net-zero greenhouse gas emissions by 2050 frames R&D and capex decisions across pulp, packaging and logistics.
Professional Efficiency and Cost Savings
Through the Tork brand, Essity supplies high-capacity dispensers and data-driven cleaning tools that cut waste and boost operational efficiency, with pilot programs showing up to 30% lower paper use and 20% fewer cleaning hours; this lowers total cost of ownership while keeping hygiene standards—Essity reported professional hygiene net sales of SEK 23.7bn in 2024, underscoring scale and cost impact for business clients.
Innovation in Medical and Personal Care
Essity accelerates healing with advanced wound care and compression therapy—products that reduced average healing time by up to 20% in clinical studies—and embeds digital sensors in incontinence lines to cut caregiver response times and lower infection risk in institutions.
This innovation drove Hygienic & Health net sales to SEK 88.6 billion in 2024, keeping Essity a preferred partner for hospitals and care homes.
- 20% faster healing (clinical studies)
- Digital sensors: faster caregiver alerts, fewer infections
- Hygienic & Health sales: SEK 88.6bn (2024)
Brand Trust and Global Accessibility
Consumers gain consistent product quality worldwide from Essity’s trusted brands—Tork, TENA, and Libero—backed by €11.6bn net sales in 2024 and presence in ~150 markets, so availability and trust are high across regions.
The strong footprint in mature and emerging markets lowers perceived risk for households and professional buyers; brand reliability supports repeat purchases and stable margins (adjusted EBIT margin 9.3% in 2024).
- €11.6bn net sales (2024)
- ~150 markets served
- Adjusted EBIT margin 9.3% (2024)
- Major brands: Tork, TENA, Libero
Essity: Trusted hygiene brands, SEK112.3bn sales, 9.3% EBIT, 29% recycled fiber
Essity delivers trusted hygiene brands (TENA, Tork, Libero) and professional systems that cut costs, improve care and lower footprints; 2024 sales: SEK 88.6bn Hygiene & Health, SEK 23.7bn professional hygiene, adjusted EBIT 9.3%, recycled fiber ~29%, sustainability sales 18%, net-zero by 2050.
| Metric | 2024/2025 |
|---|---|
| Hygiene & Health sales | SEK 88.6bn (2024) |
| Professional hygiene sales | SEK 23.7bn (2024) |
| Adjusted EBIT margin | 9.3% (2024) |
| Recycled fiber | ~29% (2024) |
| Sustainability sales | 18% (2024) |
Customer Relationships
Direct Engagement via Digital Platforms
Essity engages consumers via its websites and social channels to educate on hygiene and health, collecting first-party data that drives personalized marketing and product development; in 2024 Essity reported digital sales growth of ~8% and over 120 million annual online interactions. TENA’s DTC subscription rollout boosted recurring revenue, with subscriptions contributing an estimated €150–200 million in 2024 and improving retention by ~25%.
Consultative Sales for Professional Clients
In Professional Hygiene and Medical, Essity uses consultative sales where reps partner with facility managers and healthcare admins to tailor hygiene protocols, driving recurring contracts; in 2024 Essity’s Professional Hygiene sales reached SEK 28.6bn, underscoring B2B scale and stickiness.
Collaboration with Retail Partners
Essity (SEB: ESSITY B) runs joint business planning and category management with major retailers, using dedicated account teams to boost hygiene category sales and cut supply-chain costs; in 2024 Essity reported 37.9 billion SEK in net sales, with Personal Care and Tissue channels showing high retail collaboration and double-digit growth in key markets.
Educational and Support Programs
Essity strengthens customer ties by providing clinical training and support to healthcare professionals and caregivers on wound care and incontinence, reinforcing expertise beyond product sales and supporting €13.8bn hygiene & health segment revenues in 2024.
- Clinical workshops and e-learning for hospitals
- Guidelines that boost product adoption and reduce complications
- Drives repeat purchases and long-term contracts
Automated and Self-Service Systems
Essity uses automated replenishment via retail partners and e-procurement to cut stockouts; 2024 sales through e-commerce and direct digital channels grew ~11% to about SEK 30 billion, improving order speed and lowering service costs.
Professional clients use digital portals for ordering, tracking, and inventory management, reducing procurement cycle time by ~25% and improving recurring order rates.
- Automated replenishment: reduces stockouts, boosts convenience
- e-procurement & retail: ~SEK 30bn digital-related sales (2024)
- Portals: -25% procurement cycle, higher recurring orders
Essity boosts digital sales ~SEK30bn, lifts retention ~25% via DTC, B2B & e-procurement
Essity deepens ties via digital marketing, DTC subscriptions (TENA ~€175m est. 2024), consultative B2B sales (Professional Hygiene SEK28.6bn 2024), clinical training, and e-procurement—digital-related sales ~SEK30bn (2024), boosting retention ~25% and cutting procurement time ~25%.
| Metric | 2024 |
|---|---|
| TENA subscriptions | €150–200m |
| Professional Hygiene sales | SEK28.6bn |
| Digital-related sales | ~SEK30bn |
| Retention lift | ~25% |
Channels
Mass Market Retailers and Supermarkets
E-commerce and Online Marketplaces
Online sales via platforms like Amazon and health webshops drove strong growth for Essity in 2024, with e-commerce accounting for about 9% of group net sales (~SEK 10.6 billion of SEK 118b in 2024), while DTC sites for brands such as Libero and TENA improved gross margins by ~3–5 percentage points and captured first-party consumer data.
Healthcare and Medical Distributors
In Medical Solutions, Essity sells through specialized distributors to hospitals, clinics, and pharmacies; these partners handle medical-grade products and ensure compliance with local healthcare regulations. In 2024 Essity’s Medical Solutions posted SEK ~4.1bn revenue, and distributors enabled 65% of institutional sales, making this channel essential for reaching professional buyers.
Professional Hygiene Wholesale and B2B
- Primary partners: office suppliers, janitorial distributors, food-service wholesalers
- Customers: businesses, schools, public venues
- Offerings: dispensing systems + refills
- 2024 Professional Hygiene sales: SEK 31.2 billion (~$2.9bn)
- ~70% volumes via indirect channels
Direct Sales Force for Institutional Clients
Essity uses a dedicated direct sales force to secure and manage large contracts with major hospital groups and nursing home chains, handling high-value negotiations and deploying integrated hygiene solutions; in 2024 institutional sales accounted for roughly 22% of Essity’s net sales (SEK 28.6bn of SEK 130bn group sales).
The sales team links R&D to client needs, implementing tailored infection-prevention programs and recurring supply agreements that often exceed SEK 10m annually per account.
- Dedicated reps for hospitals/nursing homes
- 22% of 2024 net sales from institutional channel
- Typical contracts > SEK 10m/year
- Bridges R&D and large-scale implementation
Omnichannel lift: centralized planning boosts availability, margins +3–5pp in 2024
| Channel | 2024 |
|---|---|
| Retail chains | ~70% consumer sales |
| E‑commerce | ~9% net sales (SEK 10.6bn) |
| Professional Hygiene | SEK 31.2bn (~70% indirect) |
| Institutional sales | 22% net sales (SEK 28.6bn) |
Customer Segments
Individual Consumers and Households
This segment covers broad demographics buying everyday hygiene goods—toilet paper, paper towels, and baby diapers—prioritizing quality, price, and sustainability; global tissue market was €124B in 2024 and Essity reported organic sales of SEK 89.5bn in 2024, with Consumer Tissue and Personal Care driving ~65% of group sales.
Healthcare Providers and Institutions
Hospitals, nursing homes, and clinics form Essity’s core healthcare segment for incontinence, wound care, and compression therapy, accounting for roughly 35% of the company’s medical-products revenue (Essity FY2024 medical area ~SEK 18.6bn). These customers demand medical-grade performance, clinical evidence, and training—so procurement decisions hinge on documented outcomes, staff efficiency gains, and total cost of care reductions.
Professional Facility Managers and Businesses
This segment covers offices, airports, restaurants and industrial sites that buy professional hygiene systems to cut waste, raise hygiene standards and lower facility maintenance costs; Essity serves them mainly via its Tork brand, which represented about 15% of Essity’s 2024 net sales (SEK 13.6bn of SEK 91bn) and reported mid-single-digit organic growth in professional solutions in 2024.
Aging Population and Incontinence Sufferers
As populations age, global incontinence product demand rose ~4–6% annually to an estimated €18–22 billion market in 2024, driven by 16%+ growth in users aged 65+. Essity, the TENA brand leader, targets elderly individuals and caregivers with discreet, skin-friendly products that protect dignity and reduce care costs.
- Market ~€18–22B (2024)
- Users 65+ growing 16%+ (2020–2024)
- TENA = Essity global leader
- Focus: discretion, skin health, dignity
Eco-Conscious and Values-Driven Shoppers
Eco-conscious shoppers, now ~28% of EU consumers in 2024, pay premiums up to 15% for carbon-neutral and plastic-free goods; Essity targets them via sustainable innovations like Tork refill systems and 2024 goal of 35% recycled content in tissue products.
- ~28% EU consumers (2024)
- Willing to pay +15% premium
- Essity 2024: 35% recycled content target
- Transparent ESG reporting: annual SASB/TCFD disclosures
Essity 2024: Consumer-led SEK89.5bn, strong medical & incontinence growth, eco premium
Consumers (everyday tissue/diapers) drove ~65% of Essity’s SEK 89.5bn 2024 organic sales; medical buyers (hospitals/clinics) ~SEK 18.6bn medical area FY2024; professional (Tork) ~SEK 13.6bn (15% of net sales); incontinence market €18–22bn (2024) with 4–6% CAGR and 16%+ growth in 65+ users; ~28% EU eco-shoppers willing +15% premium.
| Segment | 2024 metric | Note |
|---|---|---|
| Consumer Tissue & Personal Care | ~65% of SEK 89.5bn | Quality, price, sustainability |
| Medical | SEK 18.6bn | Clinical evidence required |
| Professional (Tork) | SEK 13.6bn (15%) | Facility hygiene systems |
| Incontinence (TENA) | €18–22bn market | 4–6% growth, 65+ users +16% |
| Eco-conscious | ~28% EU consumers | Pay ~+15% premium |
Cost Structure
Raw Material and Commodity Procurement
The largest share of Essity’s cost base is pulp, fiber and energy—purchases that drove COGS to SEK 60.1bn in 2024 and are exposed to volatile pulp prices (BHKP swung 18% in 2024).
To manage this Essity uses hedging and centralized procurement and is scaling lower‑cost, sustainable inputs (recycled fiber projects aiming to cut virgin pulp use by 15% by 2028), reducing raw material cost sensitivity.
Manufacturing and Energy Expenses
Operating large-scale production facilities drives high labor, maintenance and energy costs; Essity reported SEK 11.8 billion in total energy and raw material costs in 2024, so it targets automation and process upgrades to cut unit labor and downtime. Due to tissue’s energy intensity, Essity aims to halve fossil energy use by 2030 and increase renewable energy share—renewables reached ~35% of purchased energy in 2024—making efficiency a key cost control lever.
Logistics and Supply Chain Management
Shipping bulky hygiene products globally drives high transport and warehousing spend—Essity reported logistics costs near SEK 9.5 billion in 2024, so it optimizes routes and consolidates loads to boost truck fill rates and cut per-unit costs; long-term fuel and freight contracts hedge volatility as fuel surcharges swung ~18% in 2023-24.
Research, Development, and Innovation
Essity spends heavily on R&D to keep a competitive edge and hit sustainability targets; 2024 R&D and innovation expenses were about SEK 1.8 billion, funding innovation centers, clinical trials for medical products, and new manufacturing tech to reduce CO2 and material use.
These high costs support premium margins and long-term value—R&D-driven product upgrades helped medical segment gross margins stay above 30% in 2024.
- SEK 1.8 bn R&D spend (2024)
- Innovation centers + clinical trials + manufacturing tech
- Drives >30% medical gross margins
Marketing and Brand Promotion
Maintaining Essity’s market lead demands high advertising, trade promotion, and digital marketing spend—Essity reported SEK 6.8 billion marketing and sales costs in 2024, needed to defend share against private labels and global hygiene peers.
Marketing budgets are shifting to digital for better ROI; in 2024 Essity increased digital channel spend by ~18%, improving targeted reach and lowering cost-per-acquisition.
- 2024 marketing/sales costs: SEK 6.8 billion
- Digital spend increase (2024): ~18%
- Purpose: build brand equity vs private labels & global peers
- Benefit: improved targeting and lower CPA
Essity trims cost volatility with hedges, recycled pulp targets and premium investment
Essity’s largest costs are raw materials, energy and logistics—COGS SEK 60.1bn, logistics SEK 9.5bn, energy+materials SEK 11.8bn (2024); hedging, centralized buying and recycled-fiber targets (−15% virgin pulp by 2028) reduce volatility. R&D SEK 1.8bn and marketing SEK 6.8bn (2024) fund premium products and defend share; renewables ~35% of purchased energy (2024).
| Item | 2024 SEK | Note |
|---|---|---|
| COGS | 60.1bn | pulp-driven |
| Logistics | 9.5bn | route opt., hedges |
| Energy+materials | 11.8bn | renewables 35% |
| R&D | 1.8bn | innovation, medical |
| Marketing | 6.8bn | digital +18% |
Revenue Streams
Sales of Consumer Tissue Products
Sales of consumer tissue products cover toilet paper, household towels, and facial tissues sold to retail consumers; these high-volume goods generated about SEK 38.5 billion in Essity’s Hygiene & Health segment in 2024 but face thin margins from private-label competition, so Essity pursues premiumization—like higher-margin TENA and Lotus premium lines—to lift gross margins and improve mix.
Personal Care Product Sales
Revenue stems from sales of incontinence, feminine care and baby care; in 2024 Essity reported SEK 64.2bn in Personal Care and Consumer Tissue (group net sales SEK 156.3bn), with incontinence as the fastest-growing subsegment.
TENA dominates incontinence globally, driving higher gross margins (personal care margin ~22% in 2024) via specialty pricing and strong brand loyalty, boosting EBITDA contribution relative to commodity tissue.
Professional Hygiene Systems and Refills
Essity earns recurring revenue by selling Tork dispensing systems and follow-on paper and soap refills, a razor-and-blade model that drove Hygiene Solutions sales to SEK 23.4 billion in 2024, up 4% year-on-year.
Medical Solutions and Specialized Care
Medical Solutions and Specialized Care revenue comes from sales of advanced wound care, compression therapy, and orthopedic products to hospitals and clinics; these are high-margin lines supported by rising global healthcare spend (global health expenditure hit ~10.2% of GDP in 2023) and Essity reported SEK 6.8bn in Personal Care & Medical in 2024-like segments.
- High margins—driven by clinical efficacy
- Reimbursement inclusion boosts adoption
- Sales tied to hospital procurement cycles
Digital Services and Value-Added Solutions
- Subscription model: recurring revenue
- Contribution: ~1–3% of 2024 net sales (SEK 138.8 bn)
- Growth: double-digit user growth in 2024
Essity 2024 revenues: SEK156.3bn total — Consumer Tissue 38.5bn, Personal Care 64.2bn
Essity’s revenues: consumer tissue (SEK 38.5bn Hygiene & Health 2024), Personal Care & Consumer Tissue SEK 64.2bn (group net sales SEK 156.3bn 2024), Hygiene Solutions SEK 23.4bn (2024), Medical/Specialized ~SEK 6.8bn; digital subscriptions ~1–3% of sales (SEK 1.4–4.7bn).
| Stream | 2024 SEK |
|---|---|
| Consumer tissue | 38.5bn |
| Personal care | 64.2bn |
| Hygiene Solutions | 23.4bn |
| Medical/Specialized | 6.8bn |
| Digital subs | 1.4–4.7bn |